Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 Patients.

Marques C, Carvelli J, Biard L, Faguer S, Provôt F, Matignon M, Boffa JJ, Plaisier E, Hertig A, Touzot M, Moranne O, Belenfant X, Annane D, Quéméneur T, Cadranel J, Izzedine H, Bréchot N, Cacoub P, Piedrafita A, Jourde-Chiche N, Saadoun D.

Front Immunol. 2019 Jul 18;10:1665. doi: 10.3389/fimmu.2019.01665. eCollection 2019.

2.

Rituximab associated vasculitis flare: incidence, predictors and outcome.

Desbois AC, Biard L, Sene D, Brocheriou I, Rouvier P, Lioger B, Musset L, Candon S, Zenone T, Resche-Rigon M, Piette JC, Benameur N, Cacoub P, Saadoun D.

J Rheumatol. 2019 Aug 1. pii: jrheum.190076. doi: 10.3899/jrheum.190076. [Epub ahead of print]

PMID:
31371658
3.

TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responses.

Comarmond C, Lorin V, Marques C, Maciejewski-Duval A, Joher N, Planchais C, Touzot M, Biard L, Hieu T, Quiniou V, Desbois AC, Rosenzwajg M, Klatzmann D, Cacoub P, Mouquet H, Saadoun D.

J Hepatol. 2019 Nov;71(5):908-919. doi: 10.1016/j.jhep.2019.06.029. Epub 2019 Jul 4.

PMID:
31279905
4.

Brentuximab vedotin as a bridge to allogeneic stem-cell transplantation for refractory or relapsing patients with CD30 positive anaplastic or T-cell non-Hodgkin lymphomas: a study on behalf of the SFGM-TC.

Garciaz S, Loschi M, De Masson A, Biard L, Mercier M, Tomowiak C, Delage J, Labussiere-Wallet H, Sibon D, Cassuto O, Borel C, Cornillon J, Nimubona S, Charbonnier A, Brice P, Socié G, Bouabdallah R, de Latour RP, de Fontbrune FS.

Leuk Lymphoma. 2019 Nov;60(11):2802-2805. doi: 10.1080/10428194.2019.1599112. Epub 2019 Apr 24. No abstract available.

PMID:
31014144
5.

Center Effects in Hospital Mortality of Critically Ill Patients With Hematologic Malignancies.

Biard L, Darmon M, Lemiale V, Mokart D, Chevret S, Azoulay E, Resche-Rigon M.

Crit Care Med. 2019 Jun;47(6):809-816. doi: 10.1097/CCM.0000000000003717.

PMID:
30889024
6.

Long-term health-related quality of life of critically ill patients with haematological malignancies: a prospective observational multicenter study.

Ehooman F, Biard L, Lemiale V, Contou D, de Prost N, Mokart D, Pène F, Kouatchet A, Mayaux J, Demoule A, Vincent F, Nyunga M, Bruneel F, Rabbat A, Lebert C, Perez P, Meert AP, Benoit D, Hamidfar R, Darmon M, Azoulay E, Zafrani L.

Ann Intensive Care. 2019 Jan 5;9(1):2. doi: 10.1186/s13613-018-0478-3.

7.

Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit.

Munier AL, Biard L, Legrand M, Rousseau C, Lafaurie M, Donay JL, Flicoteaux R, Mebazaa A, Mimoun M, Molina JM.

Int J Infect Dis. 2019 Feb;79:179-184. doi: 10.1016/j.ijid.2018.11.371. Epub 2018 Dec 6.

8.

Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignancies.

Mignard X, Biard L, Lemiale V, Mokart D, Pène F, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Lebert C, Perez P, Meert AP, Benoit D, Hamidfar R, Darmon M, Azoulay E, Zafrani L.

Leuk Lymphoma. 2019 May;60(5):1156-1163. doi: 10.1080/10428194.2018.1516874. Epub 2018 Oct 2.

PMID:
30277108
9.

Intensive care unit admission in patients with T cell lymphomas: clinical features and outcome.

Dumas G, Biard L, Givel C, Amorim S, Zafrani L, Lemiale V, Mariotte E, Azoulay E, Thiéblemont C, Canet E.

Ann Hematol. 2019 Jan;98(1):195-203. doi: 10.1007/s00277-018-3496-1. Epub 2018 Sep 14.

PMID:
30218163
10.

Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients.

Desbois AC, Biard L, Addimanda O, Lambert M, Hachulla E, Launay D, Ackermann F, Pérard L, Hot A, Maurier F, Mausservey C, Bernard F, Noel N, Alric L, Mirault T, Cohen F, Boussouar S, Resche-Rigon M, Cacoub P, Saadoun D.

Clin Immunol. 2018 Dec;197:54-59. doi: 10.1016/j.clim.2018.08.004. Epub 2018 Aug 18.

PMID:
30125675
11.

Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patients.

Mirouse A, Biard L, Comarmond C, Lambert M, Mekinian A, Ferfar Y, Kahn JE, Benhamou Y, Chiche L, Koskas F, Cluzel P, Hachulla E, Messas E, Cacoub P, Mirault T, Resche-Rigon M, Saadoun D; French Takayasu network.

J Autoimmun. 2019 Jan;96:35-39. doi: 10.1016/j.jaut.2018.08.001. Epub 2018 Aug 17.

PMID:
30122419
12.

Severe atypical pneumonia in critically ill patients: a retrospective multicenter study.

Valade S, Biard L, Lemiale V, Argaud L, Pène F, Papazian L, Bruneel F, Seguin A, Kouatchet A, Oziel J, Rouleau S, Bele N, Razazi K, Lesieur O, Boissier F, Megarbane B, Bigé N, Brulé N, Moreau AS, Lautrette A, Peyrony O, Perez P, Mayaux J, Azoulay E.

Ann Intensive Care. 2018 Aug 13;8(1):81. doi: 10.1186/s13613-018-0429-z.

13.

18FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients.

de Cremoux P, Biard L, Poirot B, Bertheau P, Teixeira L, Lehmann-Che J, Bouhidel FA, Merlet P, Espié M, Resche-Rigon M, Sotiriou C, Groheux D.

Oncotarget. 2018 Mar 27;9(23):16343-16353. doi: 10.18632/oncotarget.24674. eCollection 2018 Mar 27.

14.

Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.

Groheux D, Biard L, Lehmann-Che J, Teixeira L, Bouhidel FA, Poirot B, Bertheau P, Merlet P, Espié M, Resche-Rigon M, Sotiriou C, de Cremoux P.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1279-1288. doi: 10.1007/s00259-018-3998-z. Epub 2018 Apr 4.

PMID:
29616304
15.

Acute kidney injury in critically ill patients with solid tumours.

Kemlin D, Biard L, Kerhuel L, Zafrani L, Venot M, Teixeira L, Schlemmer B, Azoulay E, Canet E.

Nephrol Dial Transplant. 2018 Nov 1;33(11):1997-2005. doi: 10.1093/ndt/gfy051.

PMID:
29579262
16.

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells.

Granier C, Vinatier E, Colin E, Mandavit M, Dariane C, Verkarre V, Biard L, El Zein R, Lesaffre C, Galy-Fauroux I, Roussel H, De Guillebon E, Blanc C, Saldmann A, Badoual C, Gey A, Tartour É.

J Vis Exp. 2018 Feb 8;(132). doi: 10.3791/56606.

PMID:
29553498
17.

Severe infections in sarcoidosis: Incidence, predictors and long-term outcome in a cohort of 585 patients.

Duréault A, Chapelon C, Biard L, Domont F, Savey L, Bodaghi B, Pourcher V, Rigon MR, Cacoub P, Saadoun D.

Medicine (Baltimore). 2017 Dec;96(49):e8846. doi: 10.1097/MD.0000000000008846.

18.

Association of Prognostic Factors and Immunosuppressive Treatment With Long-term Outcomes in Neurosarcoidosis.

Joubert B, Chapelon-Abric C, Biard L, Saadoun D, Demeret S, Dormont D, Resche-Rigon M, Cacoub P.

JAMA Neurol. 2017 Nov 1;74(11):1336-1344. doi: 10.1001/jamaneurol.2017.2492.

19.

Incidence, risk factors, and outcome of multidrug-resistant Acinetobacter baumannii acquisition during an outbreak in a burns unit.

Munier AL, Biard L, Rousseau C, Legrand M, Lafaurie M, Lomont A, Donay JL, de Beaugrenier E, Flicoteaux R, Mebazaa A, Mimoun M, Molina JM.

J Hosp Infect. 2017 Nov;97(3):226-233. doi: 10.1016/j.jhin.2017.07.020. Epub 2017 Jul 25.

PMID:
28751010
20.

Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 Patients.

Comarmond C, Biard L, Lambert M, Mekinian A, Ferfar Y, Kahn JE, Benhamou Y, Chiche L, Koskas F, Cluzel P, Hachulla E, Messas E, Resche-Rigon M, Cacoub P, Mirault T, Saadoun D; French Takayasu Network.

Circulation. 2017 Sep 19;136(12):1114-1122. doi: 10.1161/CIRCULATIONAHA.116.027094. Epub 2017 Jul 12.

PMID:
28701469
21.

Composite biomarkers defined by multiparametric immunofluorescence analysis identify ALK-positive adenocarcinoma as a potential target for immunotherapy.

Roussel H, De Guillebon E, Biard L, Mandavit M, Gibault L, Fabre E, Antoine M, Hofman P, Beau-Faller M, Blons H, Danel C, Barthes FLP, Gey A, Granier C, Wislez M, Laurent-Puig P, Oudard S, Bruneval P, Badoual C, Cadranel J, Tartour E.

Oncoimmunology. 2017 Feb 21;6(4):e1286437. doi: 10.1080/2162402X.2017.1286437. eCollection 2017.

22.

Gastrointestinal emergencies in critically ill cancer patients.

Lebon D, Biard L, Buyse S, Schnell D, Lengliné E, Roussel C, Gornet JM, Munoz-Bongrand N, Quéro L, Resche-Rigon M, Azoulay E, Canet E.

J Crit Care. 2017 Aug;40:69-75. doi: 10.1016/j.jcrc.2017.03.015. Epub 2017 Mar 24.

PMID:
28363097
23.

Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma.

Granier C, Dariane C, Combe P, Verkarre V, Urien S, Badoual C, Roussel H, Mandavit M, Ravel P, Sibony M, Biard L, Radulescu C, Vinatier E, Benhamouda N, Peyromaure M, Oudard S, Méjean A, Timsit MO, Gey A, Tartour E.

Cancer Res. 2017 Mar 1;77(5):1075-1082. doi: 10.1158/0008-5472.CAN-16-0274. Epub 2016 Nov 21.

24.

Investigating covariate-by-centre interaction in survival data.

Biard L, Labopin M, Chevret S, Resche-Rigon M; Acute Leukaemia Working Party of the EBMT.

Stat Methods Med Res. 2018 Mar;27(3):920-932. doi: 10.1177/0962280216647981. Epub 2016 May 10.

PMID:
27166409
25.

Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network.

Vallet H, Seve P, Biard L, Baptiste Fraison J, Bielefeld P, Perard L, Bienvenu B, Abad S, Rigolet A, Deroux A, Sene D, Perlat A, Marie I, Feurer E, Hachulla E, Fain O, Clavel G, Riviere S, Bouche PA, Gueudry J, Pugnet G, Le Hoang P, Resche Rigon M, Cacoub P, Bodaghi B, Saadoun D; French Uveitis Network.

Arthritis Rheumatol. 2016 Jun;68(6):1522-30. doi: 10.1002/art.39667.

26.

¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen.

Groheux D, Biard L, Giacchetti S, Teixeira L, Hindié E, Cuvier C, Vercellino L, Merlet P, de Roquancourt A, de Cremoux P, Resche-Rigon M, Espié M.

J Nucl Med. 2016 Apr;57(4):536-43. doi: 10.2967/jnumed.115.163907. Epub 2015 Dec 23.

27.

Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status.

Servais S, Dumontier N, Biard L, Schnepf N, Resche-Rigon M, Peffault de Latour R, Scieux C, Robin M, Meunier M, Xhaard A, Sicre de Fontbrune F, Le Goff J, Socié G, Simon F, Mazeron MC.

Clin Microbiol Infect. 2016 Mar;22(3):289.e1-7. doi: 10.1016/j.cmi.2015.11.006. Epub 2015 Nov 25.

28.

Takayasu Arteritis and Pregnancy.

Comarmond C, Mirault T, Biard L, Nizard J, Lambert M, Wechsler B, Hachulla E, Chiche L, Koskas F, Gaudric J, Cluzel P, Messas E, Resche-Rigon M, Piette JC, Cacoub P, Saadoun D; French Takayasu Network.

Arthritis Rheumatol. 2015 Dec;67(12):3262-9. doi: 10.1002/art.39335.

29.

Impact of the source of hematopoietic stem cell in unrelated transplants: comparison between 10/10, 9/10-HLA matched donors and cord blood.

Granier C, Biard L, Masson E, Porcher R, Peffault de Latour R, Robin M, Boissel N, Xhaard A, Ribaud P, Lengline E, Larghero J, Charron D, Loiseau P, Socié G, Dhédin N.

Am J Hematol. 2015 Oct;90(10):897-903. doi: 10.1002/ajh.24112. Epub 2015 Aug 14.

30.

Long-term outcome of infliximab in severe chronic and refractory systemic sarcoidosis: a report of 16 cases.

Chapelon-Abric C, Saadoun D, Biard L, Sene D, Resche-Rigon M, Hervier B, Costedoat-Chalumeau N, Drier A, Leger JM, Cacoub P.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):509-15. Epub 2015 Jun 29.

PMID:
26120779
31.

Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroids.

Chasset F, Pages C, Biard L, Roux J, Sidina I, Madelaine I, Basset-Seguin N, Viguier M, Madjlessi-EzrA N, Schneider P, Bagot M, Resche-Rigon M, Lebbe C.

Eur J Dermatol. 2015 Jan-Feb;25(1):36-44. doi: 10.1684/ejd.2014.2471.

PMID:
25500362
32.

Behcet's disease in Budd-Chiari syndrome.

Desbois AC, Rautou PE, Biard L, Belmatoug N, Wechsler B, Resche-Rigon M, Zarrouk V, Fantin B, de Chambrun MP, Cacoub P, Valla D, Saadoun D, Plessier A.

Orphanet J Rare Dis. 2014 Sep 13;9:104. doi: 10.1186/s13023-014-0153-1. eCollection 2014.

33.

Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt.

Bonnard P, Elsharkawy A, Zalata K, Delarocque-Astagneau E, Biard L, Le Fouler L, Hassan AB, Abdel-Hamid M, El-Daly M, Gamal ME, El Kassas M, Bedossa P, Carrat F, Fontanet A, Esmat G.

J Viral Hepat. 2015 Mar;22(3):245-53. doi: 10.1111/jvh.12285. Epub 2014 Jul 30.

PMID:
25073725
34.

Permutation tests for centre effect on survival endpoints with application in an acute myeloid leukaemia multicentre study.

Biard L, Porcher R, Resche-Rigon M.

Stat Med. 2014 Jul 30;33(17):3047-57. doi: 10.1002/sim.6153. Epub 2014 Mar 28.

PMID:
24676752
35.

Case-only designs in pharmacoepidemiology: a systematic review.

Nordmann S, Biard L, Ravaud P, Esposito-Farèse M, Tubach F.

PLoS One. 2012;7(11):e49444. doi: 10.1371/journal.pone.0049444. Epub 2012 Nov 16. Review.

36.

Personal decision-making criteria related to seasonal and pandemic A(H1N1) influenza-vaccination acceptance among French healthcare workers.

Bouadma L, Barbier F, Biard L, Esposito-Farèse M, Le Corre B, Macrez A, Salomon L, Bonnal C, Zanker C, Najem C, Mourvillier B, Lucet JC, Régnier B, Wolff M, Tubach F; INFLUENCE-A Study Group.

PLoS One. 2012;7(7):e38646. Epub 2012 Jul 27.

37.

[Enigmatic bitemporal hemianopsia].

Bourguignon G, Paineau D, Flocard F, Baltenneck A, Ribot R, Biard L.

Bull Soc Ophtalmol Fr. 1987 Aug-Sep;87(7-8):1009-12. French. No abstract available.

PMID:
3427744
38.

[Is it necessary to introduce an occupational color vision capacity test in current color selection?].

Biard L, Baltenneck A, Paineau D, Bourguignon G, Vanhems G.

Bull Soc Ophtalmol Fr. 1987 Jan;87(1):79-83. French. No abstract available.

PMID:
3608036
39.

[Locoregional anesthesia and peroperative ocular immobility].

Biard L, Baltenneck A, Paineau D, Bourguignon C.

Bull Soc Ophtalmol Fr. 1986 Mar;86(3):403-5. French. No abstract available.

PMID:
3100075
40.

[Peroperative vitreous retraction: inclined position and flash administration of hypertonic mannitol].

Biard L, Batisse JL, Baltenneck A, Maucort P, Paineau M, Maigrot PC.

Bull Mem Soc Fr Ophtalmol. 1983;95:539-46. French. No abstract available.

PMID:
6428492
41.

[Congenital vertical nystagmus].

Biard L, Nicol G, Moynat B.

Bull Soc Ophtalmol Fr. 1981 Nov;81(11):1005-8. French. No abstract available.

PMID:
7340960
42.

[Angiography in the vascular keratopathies].

Biard L.

Bull Soc Ophtalmol Fr. 1978 Jan;78(1):35-6. French. No abstract available.

PMID:
729149
43.

[Ophthalmologic aspects of chronic hemodialysis].

Biard L, Weimann D, Menez B, Guidicelli CP, Perdriel G.

Ann Med Interne (Paris). 1977 Jun-Jul;128(6-7):537-9. French. No abstract available.

PMID:
921109
44.

[Neuro-ophthalmologic manifestations of expansive neoformations of the pineal region].

Biard L, Bouchard C, Desgeorges M, Decroix G.

Bull Mem Soc Fr Ophtalmol. 1976;(87):263-71. French. No abstract available.

PMID:
1268411
45.

[Relative value of procedures for weakening the small oblique muscle body].

Perdriel G, Biard L, Decroix G, Terzian M.

Bull Mem Soc Fr Ophtalmol. 1976;88:209-14. French. No abstract available.

PMID:
1029604
46.

[Complete inflammatory glaucoma. Value of corticotherapy associated with surgery].

Biard L, Terzian M, Perdriel G.

Bull Soc Ophtalmol Fr. 1975 Feb;75(2):257-9. French. No abstract available.

PMID:
1204171
47.

[Visual function in brain tumors].

Perdriel G, Biard L.

Annee Ther Clin Ophtalmol. 1975;26:89-99. French. No abstract available.

PMID:
1234754
48.

[Post-traumatic keratoendothelitis (unrecognized foreign body in the angle)].

Biard L, Terzian M, Perdriel G.

Bull Soc Ophtalmol Fr. 1974 Sep-Oct;74(9-10):899-902. French. No abstract available.

PMID:
4470018
49.

[Contributions of trabeculectomy in surgery of glaucoma].

Biard L, Perdriel G.

Bull Soc Ophtalmol Fr. 1974 Sep-Oct;74(9-10):891-7. French. No abstract available.

PMID:
4470017
50.

[Eye manifestations during Arndt-Gottron disease (papullous mucinosis)].

Vignat MJ, Biard L, Terzian M, Perdriel G.

Bull Soc Ophtalmol Fr. 1974 Apr;74(4):389-93. French. No abstract available.

PMID:
4468136

Supplemental Content

Support Center